Dow Down 1.44% Nasdaq Down 1.77%

Alcobra Ltd. (ADHD)

-NasdaqGM
12.87 Down 2.58(16.68%) 3:26PM EDT - Nasdaq Real Time Price
Prev Close:15.44
Open:15.21
Bid:12.81 x 100
Ask:12.90 x 200
1y Target Est:33.63
Beta:1.935
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:12.80 - 15.21
52wk Range:12.80 - 26.96
Volume:636,986
Avg Vol (3m):207,178
Market Cap:175.76M
P/E (ttm):N/A
EPS (ttm):-1.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ADHDDown 16.68%175.76M
JNJDown 2.30%293.70B
NVSDown 0.97%226.16B
SHPGDown 0.63%50.32B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.18
Quarterly EPS Est (Sep-14) :-0.56
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of proprietary drug candidates. It offers most advanced product (MDX) for the treatment of attention deficit hyperactivity disorder (ADHD) and other cognit... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback